Heidi Doubles Valuation to $900M in $340M Funding Round

Heidi's valuation has doubled to $900 million following a $340 million funding round, Bloomberg reports.

The round marks a sharp step up for the health-technology company, which has now raised fresh capital at double its previous valuation. Bloomberg did not name the investors or specify the round's structure in the initial report.

The figure underscores continued investor appetite for artificial-intelligence startups in the healthcare sector, even as funding markets remain selective. A $340 million raise at a $900 million valuation implies investors paid roughly 2.6 times revenue-equivalent value if the company's top line approaches $350 million — a metric Bloomberg's report did not detail.

Business Bearings could not independently verify the identity of the round's participants. Companies frequently disclose backer names and allocation breakdowns in the days after Bloomberg first reports a deal.

The raise positions Heidi to expand its AI-driven health offerings, though the company has not yet commented publicly on how it plans to deploy the capital.

Competitors in the AI-health space have also attracted significant capital this year, and a doubling of valuation in a single round suggests Heidi faced competitive term-sheet pressure from multiple investors.

The company's next challenge will be converting its elevated valuation into revenue growth that justifies the price investors paid.